Get the Stockscreener App
4.03
2.03%
0.08
Pre-market:
4.18
0.15
+3.72%
Dna X Inc stock is traded at $4.03, with a volume of 15,537.
It is up +2.03% in the last 24 hours and down -16.04% over the past month.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
See More
Previous Close:
$3.95
Open:
$3.8345
24h Volume:
15,537
Relative Volume:
0.56
Market Cap:
$6.00M
Revenue:
$27.40M
Net Income/Loss:
$-17.12M
P/E Ratio:
-0.0377
EPS:
-106.8896
Net Cash Flow:
$-24.99M
1W Performance:
+7.47%
1M Performance:
-16.04%
6M Performance:
+20.66%
1Y Performance:
-67.54%
1-Day Range:
$3.805
$4.12
1-Week Range:
$3.53
$4.69
52-Week Range:
$2.5211
$16.97
Dna X Inc Stock (SONM) Company Profile
Name
Dna X Inc
Sector
Industry
Phone
650-378-8100
Address
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
4.03 | 6.00M | 27.40M | -17.12M | -24.99M | -106.89 |
MSFT
Microsoft Corp
|
384.36 | 2.86T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
144.22 | 415.42B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
129.04 | 309.35B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
198.40 | 202.02B | 5.09B | -24.89M | 1.43B | -0.1885 |
FTNT
Fortinet Inc
|
163.73 | 119.96B | 7.11B | 1.95B | 2.44B | 2.5883 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-19 | Initiated | B. Riley FBR | Buy |
| Jul-09-19 | Upgrade | National Securities | Neutral → Buy |
| Jun-10-19 | Initiated | National Securities | Neutral |
| Jun-04-19 | Initiated | Lake Street | Buy |
| Jun-04-19 | Initiated | Oppenheimer | Outperform |
View All
Dna X Inc Stock (SONM) Latest News
12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga
SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
Sonim Technologies Strengthens Capital Structure With Preferred Financing - TipRanks
DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart
DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et
Cisco Catalyst 9300 Series Switches from Cisco Systems Inc.subscription-first campus networking p - AD HOC NEWS
Nextera Library Preparation Kit from Takara Holdings Incstreamlined NGS workflows for busy labs - AD HOC NEWS
DNA X, Inc. announced that it expects to receive $4.999998 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
Study: Gen-Z and Millennials Are Aging Faster Than Their Parents—With Alarming Health Consequences - inc.com
Price to book forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to earnings forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to sales forward of DNA X, Inc. – NASDAQ:SONM - TradingView
12 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
How DNA's Double Helix Structure Was Discovered - Encyclopedia Britannica
Enterprise value to revenue forward of DNA X, Inc. – MUN:J6P - TradingView
Alex Murdaugh defense points to unknown male DNA in push for new testing - 930 WFMD Free Talk
SONM Q3 2024 Earnings: Loss Narrows Significantly, Beats ExpectationsEarnings Miss Streak - newsline.com
Ginkgo Bioworks (DNA) director Henry Christian O receives 25,000 RSU equity grant - Stock Titan
[EFFECT] DNA X, Inc. SEC Filing - Stock Titan
DNA X | EFFECT: Others - Moomoo
DNA X Inc. (SONM) Faces Downside Pressure as Support Levels ApproachRVOL Spike - newsline.com
DNA X (SONM) deregisters 350M common shares tied to Chardan resale - Stock Titan
DNA Research Shows Your Muscles Remember How Strong and Fit You Once Were - inc.com
11 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session - Benzinga
DNA X, Inc. (formerly Sonim Technologies) Terminates Material Definitive Agreement – SEC Form 8-K Filing June 2026 - Minichart
Sonim Technologies Ends Major Equity Purchase Agreement - TipRanks
DNA X Ends $500 Million ChEF Equity Facility and Related Registration Rights With Chardan - TradingView
DNA X (NASDAQ: SONM) terminates $500M Chardan equity facility - Stock Titan
Natera Inc stock (US6323071042): insider sales and new oncology board appointments in focus - AD HOC NEWS
DNA X: Q1 Earnings Snapshot - AOL.com
Lotus Technology Inc. Unveils Eletre X: A Revolutionary Hybrid SUV Offering 1,200+ km Range and Supercar Performance Starting at €96,990 - Quiver Quantitative
12 Information Technology Stocks Moving In Tuesday's Intraday Session - Benzinga
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - Business Wire
SONMDNA X Inc Short Interest - Finviz
SONM Q3 2024 Earnings: EPS Surprises to the Upside with 22.76% Beat; Stock Rises 4%Preliminary Results - The Legal Advocate
SONM Q3 2024 Earnings: EPS Surprises Higher by 22.76%, Stock Rises Over 4%One-Time Gain Impact - The Legal Advocate
SONM Q3 2024 Earnings: EPS Beats Estimates by 22.76% Amid Cost DisciplineRetail Earnings Report - thelegaladvocate.com
DNA X Inc. (SONM) Shares Rise Nearly 6% as Buyer Interest Surges Near Key SupportSpring Pattern - dars.gov.et
S&P 500 Edges Higher as Healthcare and Tech Rally Outweigh Utility DeclinePPI Inflation Report - thelegaladvocate.com
DNA X Inc. (SONM) Rallies 4.18% as Momentum Builds Toward Key ResistanceEntry Point Alerts - The Legal Advocate
DNA X, Inc. Enters Securities Purchase Agreement with DNA Holdings Venture, Inc. and Issues Convertible Note – Key Details and Terms - Minichart
DNA X Stock Looks at Nasdaq Deadline After Latest Financing - Bez Kabli
Sonim Technologies Faces Nasdaq Delisting After New Financing - TipRanks
DNA X Received Notice of Delisting - TradingView
CIA Accused of Searching Ancestry DNA for "Alien Genetics" - hypefresh.com
Why people are losing it over Ferrari’s first all-electric car - Fast Company
DNAGinkgo Bioworks Holdings Inc Stock Price and Quote - Finviz
Dna X Inc Stock (SONM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):